Literature DB >> 18217336

Carbon nanostructures as a new high-performance platform for MR molecular imaging.

Keith B Hartman1, Lon J Wilson.   

Abstract

Over the last several years, great interest has developed in the potential use of carbon nanostructures (C60 fullerenes and nanotubes) in medicine. In some cases, medical agents derived from these materials have demonstrated greater efficacy than existing clinical agents in many imaging and therapeutic applications. This chapter provides an overall review of the application of these materials in the area of magnetic resonance imaging (MRI), with an emphasis on their future applications in targeted MR molecular imaging for the early detection of cancer and other life-threatening diseases.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18217336     DOI： 10.1007/978-0-387-76713-0_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  8 in total

1.  Development of photoactive Sweet-C60 for pancreatic cancer stellate cell therapy.

Authors:  Maciej Serda; Matthew J Ware; Jared M Newton; Sanchit Sachdeva; Martyna Krzykawska-Serda; Lam Nguyen; Justin Law; Andrew O Anderson; Steven A Curley; Lon J Wilson; Stuart J Corr
Journal:  Nanomedicine (Lond)       Date:  2018-12-03       Impact factor: 5.307

Review 2.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

Review 3.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

Review 4.  Safe clinical use of carbon nanotubes as innovative biomaterials.

Authors:  Naoto Saito; Hisao Haniu; Yuki Usui; Kaoru Aoki; Kazuo Hara; Seiji Takanashi; Masayuki Shimizu; Nobuyo Narita; Masanori Okamoto; Shinsuke Kobayashi; Hiroki Nomura; Hiroyuki Kato; Naoyuki Nishimura; Seiichi Taruta; Morinobu Endo
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

Review 5.  Targeted hyperthermia using metal nanoparticles.

Authors:  Paul Cherukuri; Evan S Glazer; Steven A Curley
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

6.  Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer.

Authors:  Zheng Han; Xiaohui Wu; Sarah Roelle; Chuheng Chen; William P Schiemann; Zheng-Rong Lu
Journal:  Nat Commun       Date:  2017-09-25       Impact factor: 14.919

Review 7.  Application of Carbon Nanoparticles in Tracing Lymph Nodes and Locating Tumors in Colorectal Cancer: A Concise Review.

Authors:  Pengcheng Liu; Jie Tan; Qiuwen Tan; Li Xu; Tao He; Qing Lv
Journal:  Int J Nanomedicine       Date:  2020-12-02

8.  Carboxylated short single-walled carbon nanotubes but not plain and multi-walled short carbon nanotubes show in vitro genotoxicity.

Authors:  Maria Mrakovcic; Claudia Meindl; Gerd Leitinger; Eva Roblegg; Eleonore Fröhlich
Journal:  Toxicol Sci       Date:  2014-12-10       Impact factor: 4.849
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.